StockData
Perspective Therapeutics, Inc. logo

Perspective Therapeutics, Inc. (CATX) stock

CATXNYSEPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 9, 2026Score 4/30
$0.75−0.03 (-3.85%)

Close on Nov 20, 2026Market cap $86.05MP/E –Yield –

Perspective Therapeutics total assets

Total assets on the balance sheet at the end of each period.

Perspective Therapeutics's total assets was $392.03M at Jun 30, 2026. For fiscal 2025 it was $266.97M, down 21.7% from the year before. Over ten years it grew 26.0% a year on average. The highest annual figure on record is $341.10M in fiscal 2024.

Annual total assets

PeriodPeriod endValueChange
FY2025Dec 31, 2025$266.97M-21.7%
FY2024Dec 31, 2024$341.10M+429.3%
FY2022Jun 30, 2022$64.44M-8.5%
FY2021Jun 30, 2021$70.42M+709.5%
FY2020Jun 30, 2020$8.70M-7.7%
FY2019Jun 30, 2019$9.42M+26.4%
FY2018Jun 30, 2018$7.46M-39.2%
FY2017Jun 30, 2017$12.27M-32.2%
FY2016Jun 30, 2016$18.10M-21.3%
FY2015Jun 30, 2015$23.00M-13.4%
FY2014Jun 30, 2014$26.55M+276.3%
FY2013Jun 30, 2013$7.06M-6.0%
FY2012Jun 30, 2012$7.51M-4.9%
FY2011Jun 30, 2011$7.89M–

Quarterly total assets

Change is against the same quarter a year earlier.

Periods
PeriodPeriod endValueChange
Q2 FY2026CQ2 2026Jun 30, 2026$392.03M+26.2%
Q1 FY2026CQ1 2026Mar 31, 2026$410.77M+24.7%
Q4 FY2025CQ4 2025Dec 31, 2025$266.97M-21.7%
Q3 FY2025CQ3 2025Sep 30, 2025$294.83M-24.6%
Q2 FY2025CQ2 2025Jun 30, 2025$310.73M-19.5%
Q1 FY2025CQ1 2025Mar 31, 2025$329.35M+18.3%
Q4 FY2024CQ4 2024Dec 31, 2024$341.10M+429.3%
Q3 FY2024CQ3 2024Sep 30, 2024$391.15M+491.6%
Q2 FY2024CQ2 2024Jun 30, 2024$385.92M+473.8%
Q1 FY2024CQ1 2024Mar 31, 2024$278.29M+305.0%
Q4 FY2022CQ2 2022Jun 30, 2022$64.44M-8.5%
Q3 FY2022CQ1 2022Mar 31, 2022$66.11M-7.2%
Q2 FY2022CQ4 2021Dec 31, 2021$67.25M+333.5%
Q1 FY2022CQ3 2021Sep 30, 2021$68.71M+756.2%
Q4 FY2021CQ2 2021Jun 30, 2021$70.42M+709.5%
Q3 FY2021CQ1 2021Mar 31, 2021$71.28M+695.4%
Q2 FY2021CQ4 2020Dec 31, 2020$15.51M+73.7%
Q1 FY2021CQ3 2020Sep 30, 2020$8.03M-20.7%
Q4 FY2020CQ2 2020Jun 30, 2020$8.70M-7.7%
Q3 FY2020CQ1 2020Mar 31, 2020$8.96M-15.3%
Q2 FY2020CQ4 2019Dec 31, 2019$8.93M-25.0%
Q1 FY2020CQ3 2019Sep 30, 2019$10.12M-24.1%
Q4 FY2019CQ2 2019Jun 30, 2019$9.42M+26.4%
Q3 FY2019CQ1 2019Mar 31, 2019$10.58M+27.1%
Q2 FY2019CQ4 2018Dec 31, 2018$11.91M+27.0%
Q1 FY2019CQ3 2018Sep 30, 2018$13.34M+23.8%
Q4 FY2018CQ2 2018Jun 30, 2018$7.46M-39.2%
Q3 FY2018CQ1 2018Mar 31, 2018$8.32M-40.3%
Q2 FY2018CQ4 2017Dec 31, 2017$9.38M-37.4%
Q1 FY2018CQ3 2017Sep 30, 2017$10.78M-35.4%
Q4 FY2017CQ2 2017Jun 30, 2017$12.27M-32.2%
Q3 FY2017CQ1 2017Mar 31, 2017$13.94M-29.6%
Q2 FY2017CQ4 2016Dec 31, 2016$14.99M-27.8%
Q1 FY2017CQ3 2016Sep 30, 2016$16.69M-23.8%
Q4 FY2016CQ2 2016Jun 30, 2016$18.10M-21.3%
Q3 FY2016CQ1 2016Mar 31, 2016$19.80M-16.1%
Q2 FY2016CQ4 2015Dec 31, 2015$20.74M–
Q1 FY2016CQ3 2015Sep 30, 2015$21.91M–
Q4 FY2015CQ2 2015Jun 30, 2015$23.00M–
Q3 FY2015CQ1 2015Mar 31, 2015$23.58M–

More Perspective Therapeutics figures

See a number that looks wrong?